Baidu
map

方润医疗完成数亿人民币B轮融资,加码高值射频微创医疗器械

2020-09-03 医谷网 医谷网

日前,位于张江科学城的方润医疗器械科技(上海)有限公司(以下简称“方润医疗”)宣布完成数亿元人民币B轮融资,中金资本旗下基金领投,千骥资本、杏泽资本、道彤投资和华兴资本跟投,此

日前,位于张江科学城的方润医疗器械科技(上海)有限公司(以下简称“方润医疗”)宣布完成数亿元人民币B轮融资,中金资本旗下基金领投,千骥资本、杏泽资本、道彤投资和华兴资本跟投,此前,方润医疗已先后完成了来自红杉资本中国、毓承资本的 A 轮融资和来自美敦力的 A+轮融资,而本轮资金将主要用于在研产品的开发、市场推广及商业化的准备工作。

方润医疗成立于2009年,专注于微创治疗产品的研制与生产,主要应用于运动医学、脊柱、耳鼻喉等领域。2016年,方润医疗全资收购了国内肿瘤介入治疗的射频消融术的先行者迈德医疗,自此拥有了等离子消融和射频消融两大核心技术。

方润医疗的低温等离子射频技术是利用超低频率电能激发介质(Nacl)产生等离子体,在40-70℃的温度范围内靠等离子体产生的动能打断分子键,将生物分子直接分解成O2,CO2,N2等气体,以微创的方式完成对软组织的汽化、消融、皱缩和止血等多种功能,产品主要应用于膝关节、肩关节、髋关节、小关节等关节镜手术,耳鼻喉手术中扁桃体切除、腺样体切除、软腭打孔、舌根打孔以及悬雍垂腭咽成形术、慢性肥厚性鼻炎、血管运动性鼻炎、过敏性鼻炎的鼻塞症状等,以及脊柱椎间盘突出的微创治疗。

目前方润医疗拥有等离子射频治疗仪、关节等离子刀头、脊柱等离子刀头、耳鼻喉等离子刀头等多项产品,获得CFDA注册12项,国家专利10项,并获得TUV产品认证及ISO 13485质量体系认证。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2036954, encodeId=eb5c2036954e5, content=<a href='/topic/show?id=88265051667' target=_blank style='color:#2F92EE;'>#微创医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50516, encryptionId=88265051667, topicName=微创医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Feb 24 16:53:09 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772031, encodeId=2f1c1e720314a, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue Aug 17 09:53:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317088, encodeId=ab0d131e088d6, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Sep 05 13:53:09 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459104, encodeId=b16c145910475, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Sep 05 13:53:09 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048146, encodeId=e05c10481461b, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 04 01:53:09 CST 2020, time=2020-09-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2036954, encodeId=eb5c2036954e5, content=<a href='/topic/show?id=88265051667' target=_blank style='color:#2F92EE;'>#微创医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50516, encryptionId=88265051667, topicName=微创医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Feb 24 16:53:09 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772031, encodeId=2f1c1e720314a, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue Aug 17 09:53:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317088, encodeId=ab0d131e088d6, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Sep 05 13:53:09 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459104, encodeId=b16c145910475, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Sep 05 13:53:09 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048146, encodeId=e05c10481461b, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 04 01:53:09 CST 2020, time=2020-09-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2036954, encodeId=eb5c2036954e5, content=<a href='/topic/show?id=88265051667' target=_blank style='color:#2F92EE;'>#微创医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50516, encryptionId=88265051667, topicName=微创医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Feb 24 16:53:09 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772031, encodeId=2f1c1e720314a, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue Aug 17 09:53:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317088, encodeId=ab0d131e088d6, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Sep 05 13:53:09 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459104, encodeId=b16c145910475, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Sep 05 13:53:09 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048146, encodeId=e05c10481461b, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 04 01:53:09 CST 2020, time=2020-09-04, status=1, ipAttribution=)]
    2020-09-05 vera_1203
  4. [GetPortalCommentsPageByObjectIdResponse(id=2036954, encodeId=eb5c2036954e5, content=<a href='/topic/show?id=88265051667' target=_blank style='color:#2F92EE;'>#微创医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50516, encryptionId=88265051667, topicName=微创医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Feb 24 16:53:09 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772031, encodeId=2f1c1e720314a, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue Aug 17 09:53:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317088, encodeId=ab0d131e088d6, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Sep 05 13:53:09 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459104, encodeId=b16c145910475, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Sep 05 13:53:09 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048146, encodeId=e05c10481461b, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 04 01:53:09 CST 2020, time=2020-09-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2036954, encodeId=eb5c2036954e5, content=<a href='/topic/show?id=88265051667' target=_blank style='color:#2F92EE;'>#微创医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50516, encryptionId=88265051667, topicName=微创医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Feb 24 16:53:09 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772031, encodeId=2f1c1e720314a, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue Aug 17 09:53:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317088, encodeId=ab0d131e088d6, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Sep 05 13:53:09 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459104, encodeId=b16c145910475, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Sep 05 13:53:09 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048146, encodeId=e05c10481461b, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 04 01:53:09 CST 2020, time=2020-09-04, status=1, ipAttribution=)]
    2020-09-04 CHANGE

    又是钱!医学需要投资呀,赞!

    0

相关资讯

医疗器械与药物一样,MAH制度全国推广

7月7日,国务院发布《关于做好自由贸易试验区第六批改革试点经验复制推广工作的通知》。《通知》指出,自贸试验区所在地方和有关部门结合各自贸试验区功能定位和特色特点,全力推进制度创新实践,形成了自贸试验区

《医疗器械拓展性临床试验管理规定(试行)》解读

为满足公众临床需要,支持并规范医疗器械拓展性临床试验的开展和安全性数据的收集,国家药品监督管理局会同国家卫生健康委员会发布了《医疗器械拓展性临床试验管理规定(试行)》。现就有关问题解读如下: 

官宣!这些器械,全国暂停出口

近日,义乌市商务局官微发布消息称,从5月10日起,全国范围暂停以市场采购贸易方式出口新型冠状病毒检测试剂、医用口罩、医用防护服、呼吸机、红外体温计等医用物资和非医用口罩(简称5+1类防疫物资)。

我国使用境内真实世界数据的医疗器械产品获批上市

3月26日,国家药监局经审查,批准了美国艾尔建公司“青光眼引流管”注册。

定了!全国医疗器械大整治,追查代理商

整治行动在5月中下旬开始,6月底结束。

试行跨区域监管,“长三角医疗器械注册人制度”又迈出一步

3月11日,上海市药监局公布《长江三角洲区域医疗器械注册人制度跨区域监管办法(试行)》(以下简称《监管办法》)。沪苏浙皖药品监督管理局对医疗器械注册人和受托生产企业,可开展监督检查、监督抽检、投诉举报

Baidu
map
Baidu
map
Baidu
map